FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...
1 Day MSM 0.13% DJIA 0.30% S&P 500 0.61% Retail/Wholesale 1.26% ...
This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback